FDA Investigator Stacey F Rivette
Stacey F Rivette has conducted inspections on 82 sites in 1 countries as of 27 Apr 2016. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
82
Last Inspection Date:
27 Apr 2016
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Stacey F Rivette:
Albert A Salvador,
Amanda B Vega,
Amy Kim,
Ana P Barido,
Andrea H Norwood,
Angel K Sandhu,
Angela E Glenn,
Anthony J Grace,
Ashley A Mutawakkil,
Ashley A Segura,
Ashley B Jelonek,
Audrey J Yarbrough,
Barbara T Carmichael,
Brant M Schroeder,
Brentley S Collins,
Brunilda Torres,
CDR Ileana Barreto Pettit,
Chinyere A Asanya,
Cody D Rickman,
Colleen M Aspinwall,
Courtney A Gilbert,
David P King,
Delkis J Caycedo,
Diane L Kelsch,
Edward A Brunt,
Emily A Baldwin,
Emily S Baldwin,
Fiorentinodc,
Gene R Gunn,
German Rivera,
Holly M Scott,
Ivan E Reyes,
Jana L Caylor,
Jason D Tenney,
Jason P Aun,
Jennifer Lalama,
Jessica L Pressley,
Joanne E King,
Joanne M Schlossin,
John A Liu,
John B Crowe,
Jolanna A Norton,
Jonathan R Campos,
Jose R Rodriguez,
Joshua J Silvestri,
Judy Ellen Ciaraldi,
Keith A Schwartz,
Kelly I Anderson,
Ladislav Kermet,
Larkin R Buckalew,
Latrice G Jones,
LCDR Randall L Morris,
Leena Thomas,
Leon L Crawley,
Leslie A Cartmill,
Linda K Matheny,
Linda S Shook,
Lindsay R Hatch,
Lindsay R Mundy,
Lisa A Warner,
LT Richard A Lyght,
Lundy H Patrick,
Lura D Baquero,
Lura D Kelly,
Madelyn Renteria,
Matthew B Thomaston,
Meredith M Cobb,
Mizanne E Lewis,
Nancy L Meade,
Ormond,
Patrick J Legler,
Raymond A Lyn, Jr,
Richard J Bashay,
Robert J Goldman,
Robert W Calais,
Rodney W Lenger,
Ronald T Weber,
Ronnie E Jackson,
Rozelle G Smith,
Samantha J Pinizzotto, D V M,
Scott T Ballard,
Sergio E Delgado,
Shavon L Square,
Shelton L Stribling,
Sherbet L Samuels,
Sonia M Monges,
Stacey F Allard,
Stephanie C Milan,
Teresa I Navas,
Teresa M Hillebrandt,
Terri E Gibson,
Thai D Truong,
Travis M Beard,
Valerie Jgrecek Trinh,
Valerie L Kelesyan
Stacey F Rivette's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2013 | EIR | Cemi International, Inc - EIR, 2013-05-08 |
March, 2013 | FDA 483 | Barbara A. Burtner - Form 483, 2013-03-20 |
April, 2013 | EIR | Winter Haven Hospital Community Blood Center - EIR, 2013-04-04 |
March, 2016 | EIR | Creative Testing Solutions - EIR, 2016-03-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more